Jennifer BROGDON

Person

Sudbury, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cancer using humanized anti-BCMA chimeric antigen rece...
- Patent number 12,214,037
- Issue date Feb 4, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 12,186,278
- Issue date Jan 7, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number RE49847
- Issue date Feb 27, 2024
- Novartis AG
- Barbara Brannetti
Information Patent Grant
Method of treating cancer by administering immune effector cells ex...
- Patent number 11,872,249
- Issue date Jan 16, 2024
- Novartis AG
- Barbara Brannetti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 11,865,167
- Issue date Jan 9, 2024
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for immunooncology
- Patent number 11,851,659
- Issue date Dec 26, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 11,578,130
- Issue date Feb 14, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Sortase synthesized chimeric antigen receptors
- Patent number 11,542,488
- Issue date Jan 3, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for ex...
- Patent number 11,459,390
- Issue date Oct 4, 2022
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 11,413,340
- Issue date Aug 16, 2022
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 11,149,076
- Issue date Oct 19, 2021
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Effective targeting of primary human leukemia using anti-CD123 chim...
- Patent number 11,028,177
- Issue date Jun 8, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number 11,026,976
- Issue date Jun 8, 2021
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using humanized anti-CD19 chimeric antigen rece...
- Patent number 10,927,184
- Issue date Feb 23, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies
- Patent number 10,870,698
- Issue date Dec 22, 2020
- Novartis AG
- Kurt Alex Heldwein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biomarkers predictive of therapeutic responsiveness to chimeric ant...
- Patent number 10,774,388
- Issue date Sep 15, 2020
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use for augmented immune response and c...
- Patent number 10,662,247
- Issue date May 26, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors comprisi...
- Patent number 10,525,083
- Issue date Jan 7, 2020
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 10,308,717
- Issue date Jun 4, 2019
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 10,287,354
- Issue date May 14, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 10,253,086
- Issue date Apr 9, 2019
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using humanized anti-CD19 chimeric antigen rece...
- Patent number 10,221,245
- Issue date Mar 5, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cardiovascular disorders with lectin-like oxidi...
- Patent number 9,988,455
- Issue date Jun 5, 2018
- Novartis AG
- Kurt Alex Heldwein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cardiovascular disorders with lectin-like oxidi...
- Patent number 9,982,046
- Issue date May 29, 2018
- Novartis AG
- Kurt Alex Heldwein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS
- Publication number 20240252538
- Publication date Aug 1, 2024
- Novartis AG
- Barbara Brannetti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN...
- Publication number 20240238396
- Publication date Jul 18, 2024
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20230374105
- Publication date Nov 23, 2023
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20230256017
- Publication date Aug 17, 2023
- Novartis AG
- Jennifer BROGDON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20230174933
- Publication date Jun 8, 2023
- Novartis AG
- Jennifer BROGDON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20230052970
- Publication date Feb 16, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230026049
- Publication date Jan 26, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...
- Publication number 20230000964
- Publication date Jan 5, 2023
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...
- Publication number 20220387486
- Publication date Dec 8, 2022
- Novartis AG
- Barbara Brannetti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20220364055
- Publication date Nov 17, 2022
- Novartis AG
- Louise Treanor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20220195010
- Publication date Jun 23, 2022
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME
- Publication number 20210396739
- Publication date Dec 23, 2021
- Novartis AG
- Iulian Pruteanu-Malinici
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECE...
- Publication number 20210284752
- Publication date Sep 16, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20210220404
- Publication date Jul 22, 2021
- Novartis AG
- Aida Abujoub
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20210172020
- Publication date Jun 10, 2021
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20210071182
- Publication date Mar 11, 2021
- Novartis AG
- Jennifer BROGDON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND C...
- Publication number 20210015860
- Publication date Jan 21, 2021
- Novartis AG
- Jennifer BROGDON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY
- Publication number 20200339651
- Publication date Oct 29, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...
- Publication number 20200113941
- Publication date Apr 16, 2020
- Novartis AG
- Barbara Brannetti
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRVIII CHIMERIC ANTIGEN...
- Publication number 20190330356
- Publication date Oct 31, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20190292238
- Publication date Sep 26, 2019
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190263914
- Publication date Aug 29, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBI...
- Publication number 20190151365
- Publication date May 23, 2019
- Novartis AG
- Oezlem Anak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECE...
- Publication number 20190135940
- Publication date May 9, 2019
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jennifer BROGDON

Person

Patents Grantslast 30 patents

Treatment of cancer using humanized anti-BCMA chimeric antigen rece...

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Method of treating cancer by administering immune effector cells ex...

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Compositions and methods for immunooncology

Treatment of cancer using a CD123 chimeric antigen receptor

Regulatable chimeric antigen receptor

Sortase synthesized chimeric antigen receptors

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for ex...

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Anti-BCMA chimeric antigen receptor

Effective targeting of primary human leukemia using anti-CD123 chim...

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Treatment of cancer using humanized anti-CD19 chimeric antigen rece...

Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies

Biomarkers predictive of therapeutic responsiveness to chimeric ant...

Treatment of cancer using a CD123 chimeric antigen receptor

Compositions and methods of use for augmented immune response and c...

Treatment of cancer using a CLL-1 chimeric antigen receptor

Nucleic acid molecules encoding chimeric antigen receptors comprisi...

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Regulatable chimeric antigen receptor

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Treatment of cancer using humanized anti-CD19 chimeric antigen rece...

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Methods of treating cardiovascular disorders with lectin-like oxidi...

Methods of treating cardiovascular disorders with lectin-like oxidi...

Patents Applicationslast 30 patents

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTORS

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-...

NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME

TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECE...

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

COMPOSITIONS AND METHODS OF USE FOR AUGMENTED IMMUNE RESPONSE AND C...

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

NUCLEIC ACID MOLECULES ENCODING CHIMERIC ANTIGEN RECEPTORS COMPRISI...

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRVIII CHIMERIC ANTIGEN...

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBI...

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECE...